Elyda Golçalves De Lima
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Elyda Golçalves De Lima has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Antonio Carlos de Freitas
Laboratory of Molecular Studies and Experimental Therapy—LEMTE, Department of Genetics, Federal University of Pernambuco, Recife 50670-901, Brazil
2 shared publications - Ana Pavla Almeida Diniz Gurgel
Laboratory of Molecular Genetics (LAGEM), Department of Engineering and Environment, Federal, University of Paraiba, Rio Tinto, 58297-000 Paraiba, Brazil, Brazil
1 shared publication - Ana Pavla Almeida Diniz Gurgel
Laboratory of Molecular Studies and Experimental Therapy, Department of Genetics, Federal University of Pernambuco, Pernambuco, Brazil
1 shared publication - Antonio Roberto Lucena Araujo
Department of Genetics, Federal University of Pernambuco, Recife, Brazil
1 shared publication - Bianca De França São Marcos
Laboratory of Molecular Studies and Experimental Therapy, Department of Genetics, Federal University of Pernambuco, Cidade Universitária, Av Professor Moraes Rêgo S/N, Recife, Pernambuco, 50670-901, Brazil
1 shared publication - Bárbara Simas Chagas
Laboratory of Molecular Studies and Experimental Therapy, Department of Genetics, Federal University of Pernambuco, Pernambuco, Brazil
1 shared publication
Latest Publications
- Open Access
- 23 April 2024
- Published by Universidade Federal de Pernambuco in Gestão.org
- Vol. 22 (1)
Evolução da inteligência artificial como uma ferramenta para administração
Objetivo: O presente estudo foi desenvolvido de modo a analisar as maneiras que a inteligência artificial (IA) vem sendo utilizada como ferramenta para otimizar processos administrativos. Para tanto, debruça-se sobre as produções acadêmicas de administração e áreas correlatas sobre o tema. Método/abordagem: Uma revisão bibliográfica qualitativa foi adotada, baseada em artigos científicos disponíveis na plataforma SPELL, com seleção e análise de 22 estudos publicados entre 2020 e 2024, utilizando a palavra-chave "Inteligência Artificial" Contribuições teóricas/práticas/sociais: Ao sistematizar as discussões acadêmicas sobre IA na administração, o estudo identificou duas principais perspectivas: seu uso em instituições públicas e em diversos setores da Administração. Logo, o estudo aponta o crescimento da popularidade de softwares em técnicas administrativas que já foram ponderadas por pesquisadores desta área de estudos. Além disso, indica o crescente alerta sobre implicações éticas e limitações das IA. Originalidade/relevância: O estudo contribui ao mapear tendências recentes e ao consolidar o papel da IA como ferramenta estratégica para a tomada de decisões em um ambiente organizacional dinâmico e complexo.
- 23 April 2024
- Published by Universidade Federal de Pernambuco in Gestão.org
- Vol. 22 (1)
Open AccessEvolução da inteligência artificial como uma ferramenta para administração
Objetivo: O presente estudo foi desenvolvido de modo a analisar as maneiras que a inteligência artificial (IA) vem sendo utilizada como ferramenta para otimizar processos administrativos. Para tanto, debruça-se sobre as produções acadêmicas de administração e áreas correlatas sobre o tema. Método/abordagem: Uma revisão bibliográfica qualitativa foi adotada, baseada em artigos científicos disponíveis na plataforma SPELL, com seleção e análise de 22 estudos publicados entre 2020 e 2024, utilizando a palavra-chave "Inteligência Artificial" Contribuições teóricas/práticas/sociais: Ao sistematizar as discussões acadêmicas sobre IA na administração, o estudo identificou duas principais perspectivas: seu uso em instituições públicas e em diversos setores da Administração. Logo, o estudo aponta o crescimento da popularidade de softwares em técnicas administrativas que já foram ponderadas por pesquisadores desta área de estudos. Além disso, indica o crescente alerta sobre implicações éticas e limitações das IA. Originalidade/relevância: O estudo contribui ao mapear tendências recentes e ao consolidar o papel da IA como ferramenta estratégica para a tomada de decisões em um ambiente organizacional dinâmico e complexo.
- Open Access
- 8 November 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (21) , 5209
Detection of Human Papillomavirus DNA in Paired Peripheral Blood and Cervix Samples in Patients with Cervical Lesions and Healthy Individuals
This study evaluated the presence of Human Papillomavirus (HPV) DNA in the cervix and peripheral blood of women with cervical intraepithelial neoplasia (CIN I, II, and III) and healthy individuals. Overall, 139 paired peripheral blood and cervix samples of healthy women and women with CIN I, II, and III (n = 68) were tested for HPV DNA by using standard procedures. Polymerase chain reaction (PCR) sequencing determined HPV types. Quantification of HPV16 E6 and E2 genes was performed to determine viral load and physical state. HPV DNA was detected in the cervix (21.1% in healthy individuals; 48.8–55.5% in CIN patients), blood (46.4% in healthy individuals; 44.1–77.7% in CIN patients) and paired peripheral blood and cervix samples (24% in healthy individuals; 32.5–44.4% in CIN patients). The most frequent types found in the cervix were HPV16, 18, 31, 33, 58, and 70, while HPV16, 18, 33, 58, and 66 were the most frequent types found in the blood. HPV DNA in the cervix was associated with previous sexually transmitted infections (STIs) (p = 0.023; OR: 2.978; CI:1.34–7.821), HPV DNA in the blood (p = 0.000; OR: 8.283; CI:3.700–18.540), and cervical lesions (CIN I/II or III) (p = 0.007). Binomial logistic regression showed that HPV DNA in the blood (p = 0.000; OR: 9.324; CI:3.612–24.072) and cervical lesions (p = 0.011; OR: 3.622; CI:1.338–9.806) were associated with HPV DNA in the cervix. However, we did not find an association between HPV DNA in the blood and cervical lesions (p = 0.385). Our results showed that only HPV DNA found in the cervix was associated with cervical lesions.
- 8 November 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (21) , 5209
Open AccessDetection of Human Papillomavirus DNA in Paired Peripheral Blood and Cervix Samples in Patients with Cervical Lesions and Healthy Individuals
This study evaluated the presence of Human Papillomavirus (HPV) DNA in the cervix and peripheral blood of women with cervical intraepithelial neoplasia (CIN I, II, and III) and healthy individuals. Overall, 139 paired peripheral blood and cervix samples of healthy women and women with CIN I, II, and III (n = 68) were tested for HPV DNA by using standard procedures. Polymerase chain reaction (PCR) sequencing determined HPV types. Quantification of HPV16 E6 and E2 genes was performed to determine viral load and physical state. HPV DNA was detected in the cervix (21.1% in healthy individuals; 48.8–55.5% in CIN patients), blood (46.4% in healthy individuals; 44.1–77.7% in CIN patients) and paired peripheral blood and cervix samples (24% in healthy individuals; 32.5–44.4% in CIN patients). The most frequent types found in the cervix were HPV16, 18, 31, 33, 58, and 70, while HPV16, 18, 33, 58, and 66 were the most frequent types found in the blood. HPV DNA in the cervix was associated with previous sexually transmitted infections (STIs) (p = 0.023; OR: 2.978; CI:1.34–7.821), HPV DNA in the blood (p = 0.000; OR: 8.283; CI:3.700–18.540), and cervical lesions (CIN I/II or III) (p = 0.007). Binomial logistic regression showed that HPV DNA in the blood (p = 0.000; OR: 9.324; CI:3.612–24.072) and cervical lesions (p = 0.011; OR: 3.622; CI:1.338–9.806) were associated with HPV DNA in the cervix. However, we did not find an association between HPV DNA in the blood and cervical lesions (p = 0.385). Our results showed that only HPV DNA found in the cervix was associated with cervical lesions.
- 29 June 2016
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 142 (12) , 2415-2427
Human papillomavirus and lung cancinogenesis: an overview
Lung cancer is the most common cause of cancer deaths worldwide. Although tobacco smoking is considered to be the main risk factor and the most well-established risk factor for lung cancer, a number of patients who do not smoke have developed this disease. This number varies between 15 % to over one-half of lung cancer cases, and the deaths from lung cancer in non-smokers are increasing every year. There are many other agents that are thought to be etiological, including diesel exhaust exposure, metals, radiation, radon, hormonal factors, cooking oil, air pollution and infectious diseases, such as human papillomavirus (HPV). Studies in various parts of the world have detected HPV DNA at different rates in lung tumors. However, the role of HPV in lung cancer is still unclear. Thus, in this review, we investigated some molecular mechanisms of HPV protein activity in host cells, the entry of HPV into lung tissue and the possible route used by the virus to reach the lung cells.
- 29 June 2016
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 142 (12) , 2415-2427
Human papillomavirus and lung cancinogenesis: an overview
Lung cancer is the most common cause of cancer deaths worldwide. Although tobacco smoking is considered to be the main risk factor and the most well-established risk factor for lung cancer, a number of patients who do not smoke have developed this disease. This number varies between 15 % to over one-half of lung cancer cases, and the deaths from lung cancer in non-smokers are increasing every year. There are many other agents that are thought to be etiological, including diesel exhaust exposure, metals, radiation, radon, hormonal factors, cooking oil, air pollution and infectious diseases, such as human papillomavirus (HPV). Studies in various parts of the world have detected HPV DNA at different rates in lung tumors. However, the role of HPV in lung cancer is still unclear. Thus, in this review, we investigated some molecular mechanisms of HPV protein activity in host cells, the entry of HPV into lung tissue and the possible route used by the virus to reach the lung cells.